What Is a Good EBITDA for a Medical Practice? Benchmarks & Valuation Guide

Quick answer: As a directional benchmark, an EBITDA margin of 15% to 20% is generally healthy for many established medical practices, while the broader range for well-run practices can fall around 10% to 20%, depending on specialty, size, payer mix, and business model. Procedure-heavy specialties may achieve higher margins. There is no universal figure, because EBITDA varies by specialty, practice size, payer mix, ancillary revenue, physician compensation, and how dependent the practice is on the departing owner. And the margin that matters to a buyer is the adjusted one — earnings normalized for owner compensation and one-time costs, documented well enough that a lender’s appraiser can verify it.

You have spent decades measuring your practice by patients seen, outcomes delivered, and staff kept. Then a buyer, a lender, or an advisor asks about EBITDA — a term that appears nowhere in clinical training — and the conversation shifts into a language you were never taught. This guide translates it, gives you the benchmarks, and shows you what the number is worth in a sale.

What Is a Good EBITDA Margin for a Medical Practice?

In one line: Most healthy established practices land between 15% and 20%, but the benchmark that matters is your own specialty peer set.

EBITDA margin is EBITDA divided by net revenue — the share of every dollar collected that survives as operating profit. What is good EBITDA in practice depends on your model, but published benchmarking gives you a starting point.

Broad industry benchmarks often place EBITDA margins for well-run medical practices in the 10% to 20% range, although the appropriate benchmark varies by specialty, practice size, payer mix, and business model, with practices sustaining margins above that range often attracting premium valuations (SovDoc, Benchmarking Your Medical Practice, 2025). Specialty-level analysis puts dermatology around 25% to 35%, orthopedics 20% to 30%, urgent care 15% to 20%, and primary care 10% to 20%, with the spread driven largely by payer mix and procedural revenue (ProfitUp Advisory, Healthcare Practice Profit Margins, 2025).

Medical Practice EBITDA Margin Benchmark Table

These are directional benchmarks, not valuation standards. They tell you roughly where your practice sits relative to peers. They do not tell you what it is worth.

Why the Benchmark Is Only a Starting Point

•  Specialty sets the ceiling. Procedure-based and cash-pay specialties carry structurally higher contribution margins than insurance-dependent primary care.
•  Owner compensation distorts the raw figure. If you pay yourself well above or below market, your reported margin is not comparable to anyone else’s.
• Margin quality is about who produces it. If most collections run through one physician who is leaving, a strong margin on paper may not transfer to a buyer.
• A defensible margin beats a high one. Buyers pay for earnings they believe will still be there in year two.

What Is EBITDA?

In one line: EBITDA measures operating profitability before financing, tax, and non-cash charges — which lets two practices be compared on operations alone.

So what is EBITDA? It stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. What is EBITDA in business terms: a measure of operating profitability that strips out decisions which vary between owners rather than between businesses.

EBITDA can indicate operating profitability, but it is not the same as actual cash flow available to the owner. A practice may have strong EBITDA while still requiring cash for working capital, capital expenditures, debt payments, and taxes. New imaging equipment does not stop being a real cost because it appears as depreciation, and a buyer’s lender will not treat it that way.

•  Earnings — start with net income from the P&L.
•  Interest — added back, because one owner’s practice carries debt and another’s does not.
• Taxes — added back, because entity structure and state of operation distort comparison.
• Depreciation and amortization — added back, because they are non-cash charges reflecting past capital decisions, not current performance.

How to Calculate EBITDA

In one line: Two routes to the same figure — build up from net income, or build down from revenue.

The build-up method:

EBITDA = Net income + Interest + Taxes + Depreciation + Amortization

The operating method:

EBITDA = Net revenue − Operating expenses (excluding interest, taxes, depreciation, and amortization)

A simple medical practice illustration:

What Is Adjusted EBITDA?

In one line: Buyers, lenders, and appraisers typically do not rely on raw EBITDA from a physician-owned P&L alone. They generally assess adjusted or normalized EBITDA after accounting for owner compensation, discretionary expenses, and non-recurring items.

Adjusted EBITDA — sometimes called normalized EBITDA — restates earnings as they would appear under a new, arm’s-length owner. It is the figure buyers, appraisers, and lenders actually work from. Terminology matters here: EBITDA and adjusted EBITDA are non-GAAP measures, and the SEC’s own guidance on non-GAAP financial measures treats the adjustments as requiring clear definition rather than assumption. The same discipline applies in a private practice sale — an adjustment you cannot define and evidence is an adjustment a buyer will strike.

Common EBITDA Add-Backs for Medical Practices

In one line: Buyers do not reject add-backs for being aggressive — they reject them for being unverifiable.

Every add-back needs a document behind it — an invoice, a contract, a payroll record. Buyers discount what they cannot verify, and lenders’ appraisers discount it harder. An add-back schedule with evidence attached is worth real money; one built on assertion costs you credibility at exactly the wrong moment.

EBITDA vs SDE: Which One Applies to Your Practice

In one line: Owner-operated practices are usually analyzed on SDE; larger, multi-provider practices on adjusted EBITDA.

A practice cannot be valued on an SDE-sized number using an EBITDA-sized multiple. That mismatch is one of the most common and most expensive errors in physician practice valuation. The full mechanics of the first basis are covered in our companion guide to seller’s discretionary earnings.

Medical Practice EBITDA Multiples

In one line: EBITDA valuation applies a multiple to normalized earnings, and scale is one of the most important factors influencing the EBITDA multiple, along with specialty, growth, provider concentration, payer mix, geography, and buyer type.

EBITDA multiples by industry are widely published, and healthcare services generally sits above the small-business average because of demand durability and buyer competition. Within healthcare, the clearest pattern is size.

Directional ranges reported for healthcare and medical practices in 2026 (ClearlyAcquired, Average EBITDA Multiples for Healthcare and Medical Practices, 2026):

Specialty matters on top of scale. Reported directional ranges include primary care around 3x–5x, dermatology 6x–8x, and orthopedics 7x–10x, with procedure-heavy specialties at the top of the range (Sofer Advisors, Medical Practice Valuation Multiples 2025–2026, 2026).

Treat all of these as directional, not as a quotation. They are drawn from market commentary, not from a valuation of your practice, and the spread between the lowest and highest multiple paid within a single specialty is routinely wider than the difference between two specialties.

Factors That Increase a Practice’s EBITDA Multiple

•  Practice size and the absolute size of the earnings base
• Specialty and the depth of the buyer pool in it
•  Revenue spread across multiple providers rather than concentrated in the seller
•  Strong commercial payer mix with stable contracts
•  Growth trajectory and remaining capacity
•  Ancillary and recurring revenue streams
• Geographic market — underserved beats saturated
•  Clean, normalized financials across three-plus years
•  Buyer type, and whether more than one credible buyer is competing

Example: How EBITDA Affects Medical Practice Value

In one line: The adjustments, not the headline earnings, usually decide the number.

Take the practice from the calculation above:

Applying an illustrative 6x multiple:

$430,000 × 6 = $2,580,000 enterprise value

The 6x multiple here is illustrative only — it is not a market rate, a quotation, or a guarantee. It is used to show the mechanism. Note what the arithmetic reveals: $130,000 of documented adjustments moved the indicated value by $780,000. That is why add-back documentation is worth more attention than almost anything else you can do in the year before a sale — and why an undocumented add-back is not a rounding error.

Enterprise value is also not what lands in your account. Debt, cash, working-capital adjustments, transaction costs, and above all tax structure sit between the two.

How to Improve EBITDA Before Selling

In one line: Most of what drives EBITDA is improvable — on a 12-to-24-month runway, not a 90-day one.

• Clean the books first. Separate personal from practice spending, reconcile monthly, and produce three years of consistent statements. Lowest cost, highest return.
• Reduce provider dependence. Add or retain an associate, use advanced practice providers appropriately, and build patient loyalty to the practice rather than to you personally.
•  Review the payer contracts. Renegotiate underperformers and document the commercial mix.
• Address revenue cycle leakage. Denial rates, days in A/R, and coding accuracy flow straight to the bottom line.
• Retain the team. Tenured staff with documented roles are both a margin story and a transferability story.
•  Rationalize real costs carefully. Cutting spend a buyer must restore does not create value; it creates a diligence question.
•  Build the add-back schedule as you go. Documenting contemporaneously is far easier than reconstructing under a diligence deadline.

Common EBITDA Mistakes Medical Practice Owners Make

In one line: Most of these are unforced, and all of them are visible to a buyer’s lender.

•  Mixing personal and business expenses. It makes every add-back harder to prove and casts doubt on the whole file.
•  Using unsupported add-backs. An adjustment without a document is an assertion, and it will be struck.
• Failing to normalize physician compensation. The largest single adjustment, and the one most often skipped.
• Ignoring provider dependence. Earnings that walk out with you are not earnings a buyer will pay a full multiple for.
• Treating EBITDA as cash flow. It excludes debt service, taxes, working capital, and capital expenditure.
• Applying an EBITDA multiple to an SDE figure. Or the reverse. Either produces a badly wrong number.
• Waiting until the sale process to clean the records. Three years of clean statements cannot be created in three months.
• Ignoring recurring capital expenditure. A suppressed equipment budget reads to an appraiser as future cost, not present earnings.

Key Takeaways

•  A healthy EBITDA margin for an established medical practice is directionally 15% to 20%, with above 20% indicating strong profitability — but specialty, payer mix, size, and owner compensation move the benchmark substantially.
•  EBITDA measures operating profitability, not cash flow. It excludes working capital, capital expenditure, debt service, and taxes.
•  Buyers and lenders work from adjusted EBITDA: owner compensation reset to market, discretionary and one-time items removed, every adjustment documented.
• Scale is one of the key factors influencing the multiple, along with specialty, growth, provider concentration, payer mix, geography, buyer type, and financial quality.
• Owner-operated practices are generally analyzed on SDE, larger ones on adjusted EBITDA. Never apply one basis’s multiple to the other’s figure.
• Documented adjustments are leveraged: at a 6x multiple, every $10,000 of defensible add-back moves indicated value by $60,000.
•  Most meaningful EBITDA improvement takes 12 to 24 months, which is the strongest argument for getting a valuation years before you intend to act.

Also Read: Comparing EBITDA Vs SDE in Medical Practice Valuations

The Bottom Line

There is no universal good EBITDA for a medical practice — there is a healthy range, and then there is a defensible number. Benchmarks tell you where you stand; only a valuation built on your own normalized financials tells you what you are worth. If you want that number, an independent medical practice valuation is where it starts — whether you plan to act this year or simply want to understand your position. When you’re ready, we’re here.

Frequently Asked Questions